Low-dose dengue virus 3 human challenge model: a phase 1 open-label study.
Waickman AT, Newell K, Lu JQ, Fang H, Waldran M, Gebo C, Currier JR, Friberg H, Jarman RG, Klick MD, Ware LA, Endy TP, Thomas SJ.
Waickman AT, et al.
Nat Microbiol. 2024 May;9(5):1356-1367. doi: 10.1038/s41564-024-01668-z. Epub 2024 Apr 1.
Nat Microbiol. 2024.
PMID: 38561497
Clinical Trial.